Fusion Finance Limited has submitted a regulatory disclosure to the National Stock Exchange of India Limited and BSE Limited regarding scheduled meetings with analysts and institutional investors. The filing is made in accordance with Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
The company has scheduled analyst and institutional investor meetings to be attended by company management on November 4 to November 5, 2026. The meetings will involve a group of investors and will include both one-to-one meetings and group meetings. All meetings will be conducted in-person in Mumbai.
The disclosure explicitly states that during the course of these investor meetings, no unpublished price sensitive information will be shared with participants. The company also notes that the schedule is subject to changes which may occur due to exigencies on the part of either the analysts/investors or the company itself.
A copy of this intimation letter is available on the company's website at www.fusionfin.com. The document was digitally signed by Vikrant Sadana, Company Secretary & Compliance Officer, from Gurugram on October 29, 2026 at 11:45:59 IST.